期刊文献+

2007年北京市新入血液透析患者病因组成分析 被引量:11

Etiology analysis of incident hemodialysis patients in Beijing in 2007
在线阅读 下载PDF
导出
摘要 目的分析北京市2007年新增血液透析患者的年龄、性别、病因特点,为制定预防措施提供参考。方法根据北京市血液透析质量控制和改进中心肾脏病数据系统(BJHDQCIC)提供的数据,对2007年在北京市血液净化中心首诊并进行维持性血液透析的患者的年龄、性别病因进行分析。结果该年度新增血液透析患者1732例,男女构成比1.35:1,年龄41~80岁之间占73.6%。病因前三位为原发肾小球疾病的占27.97%,糖尿病占23.19%,高血压占13.21%。在51~80岁人群中,糖尿病已成为首要病因。结论与过去五年的病因构成相比较,原发性肾小球疾病的构成比逐渐下降,但仍为主要病因,以50岁以下中青年为多。糖尿病构成比较往年增加。糖尿病已成为新进入血液透析的中老年患者的首要病因。 Objective To investigate age, sex and primary disease of incident hemodialysis patients with end stage renal disease (ESRD) in Beijing in 2007. Methods Based on the information from the database issued by Beijing Hemodialysis Quality Control Improvement Center (BJHDQCIC), we analyzed age, sex and primary disease in 1 732 ESRD patients newly treated with hemodialysis in Beijing in 2007. Results In 2007 in Beijing, 1 732 cases began to treated with hemodialysis. The male/female ratio was 1.35:1, and 73.6% patients were in the age range of 41-80 years. The most frequent primary diseases were primary glomerulonephritis 27.97%, diabetic nephropathy 23.19%, and hypertensive nephropathy 13.21%. Conclusion In this study, the major primary disease leading to ESRD and hemodialysis was primary glomerulonephritis. In the recent 5 years, however, the ratio of primary glomerulonephritis in the hemodialysis patients is decreasing, and that of diabetic nephropathy is increasing.
作者 陈洪 周春华
出处 《中国血液净化》 2009年第10期567-570,共4页 Chinese Journal of Blood Purification
关键词 血液透析 年龄 性别 病因 Hemodialysis Age Sex Etiology
  • 相关文献

参考文献8

  • 1Boenisch O, Ehmke KD, Heddergott A, el al.C reactive protein and cytokine plasma levels in hemodialysis patients [J].J Soc Nephrol, 2002,15:547-551.
  • 2Schomig M, Eisenhandt A, Ritz E. The microinflammatory state of uremia [J].Blood Purif, 2000,18:327-332.
  • 3Soledad Garc?'a de Yinuesa Insulin Resistance, Inflammatory Biomarkers, and Adipokines in Patients with Chronic Kidney Disease: Effects of Angiotensin II Blockade[J]. Am Soc Nephrol, 2006,17:S206-s212.
  • 4Taskapan MC, Taskapan H, Sahin I and Keskin L, el al. Serum Leptin, Resistin, and Lipid Levels in Patients with End Stage Renal Failure with Regard to Dialysis Modality [J]. Renal Failure, 2007, 29:147-154.
  • 5Lehrke M, Reilly MD, Millington S C, et al. An inflammatory cascade leading to hyperresistinemia in human [J].Plos Med, 2004,1:41-45.
  • 6Suzuki Y,Ruiz-Ortega M, Lorenzo O, el al. Inflammation and angiotensin II. Int[J] Biochem Cell Biol, 2003,35:881 900.
  • 7Marshall TG, Lee RE, Marshall FE. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b[J].Theor Biol Med Model, 2006,3:1- 33.
  • 8Fliser D, Buchholz K, Haller H, et al. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation[J]. Circulation, 2004,110:1103-1107.

同被引文献110

引证文献11

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部